These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29954633)

  • 21. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Compound Sclerosant: Polidocanol-Bleomycin Foam.
    Hanshu Z; Shaohua L; Anwei C
    Dermatol Surg; 2020 Dec; 46(12):1712-1714. PubMed ID: 32769523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimental Study on Influence of Driving Speed on Foam Stability in Sclerotherapy for the Treatment of Varicose Veins].
    Bai T; Jiang W; Zhao W; Wan H; Fan Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Oct; 33(5):890-5. PubMed ID: 29714941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current applications of foams formed from mixed surfactant-polymer solutions.
    Bureiko A; Trybala A; Kovalchuk N; Starov V
    Adv Colloid Interface Sci; 2015 Aug; 222():670-7. PubMed ID: 25455806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of environmental and compositional manipulations on the longevity of Tessari-made foam for sclerotherapy.
    Patel SB; Ostler AE; Dos Santos SJ; Piriea TM; Whiteley MS
    J Vasc Surg Venous Lymphat Disord; 2015 Jul; 3(3):312-8. PubMed ID: 26992311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Modiied 3-Way Tap to Enhance the Stability and Uniformity of Sclerosant Foam.
    Zhang H; Yang A; Xu M; Liu S
    Ann Vasc Surg; 2021 Jan; 70():501-505. PubMed ID: 32889163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experimental study on the relationship between foam pressure difference and foam stability].
    Bai T; Liu J; Jiang W; Li Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2022 Apr; 39(2):353-358. PubMed ID: 35523557
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying the Most Stable State of a Foam Sclerosant for Foam Sclerotherapy.
    Zhang HS; Yang AJ; Liu S
    Dermatol Surg; 2020 Oct; 46(10):e66-e70. PubMed ID: 31895253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. O/W emulsions stabilised by both low molecular weight surfactants and colloidal particles: The effect of surfactant type and concentration.
    Pichot R; Spyropoulos F; Norton IT
    J Colloid Interface Sci; 2010 Dec; 352(1):128-35. PubMed ID: 20817195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of the calibre and length of needle on the stability of sclerosing foam.
    Skuła M; Hobot J; Czaja J; Simka M
    Phlebology; 2021 May; 36(4):322-328. PubMed ID: 33236673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polidocanol concentration and time affect the properties of foam used for sclerotherapy.
    VAN Deurzen B; Ceulen RP; Tellings SS; VAN DER Geld C; Nijsten T
    Dermatol Surg; 2011 Oct; 37(10):1448-55. PubMed ID: 21790848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of sclerosant foams by mechanical methods increases the foam temperature.
    Tan L; Wong K; Connor D; Fakhim B; Behnia M; Parsi K
    Phlebology; 2017 Aug; 32(7):501-505. PubMed ID: 27738239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An investigation on the influence of glycerin on sclerosant foam stability.
    Peterson JD; Goldman MP
    Phlebology; 2011 Sep; 26(6):232-4. PubMed ID: 21415429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laser beams interaction with polidocanol foam: molecular background.
    Smarandache A
    Photomed Laser Surg; 2012 May; 30(5):262-7. PubMed ID: 22417110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low temperature offers better foam stability.
    Serkan M; Gokay D
    J Cosmet Dermatol; 2024 Oct; 23(10):3366-3371. PubMed ID: 38837644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the difference between foams stabilized by surfactants and whole casein or beta-casein. comparison of foams, foam films, and liquid surfaces studies.
    Maldonado-Valderrama J; Langevin D
    J Phys Chem B; 2008 Apr; 112(13):3989-96. PubMed ID: 18324808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surfactant selection for a liquid foam-bed photobioreactor.
    Janoska A; Vázquez M; Janssen M; Wijffels RH; Cuaresma M; Vílchez C
    Biotechnol Prog; 2018 May; 34(3):711-720. PubMed ID: 29388352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polydocanol foam stabilized by liposomes: Supramolecular nanoconstructs for sclerotherapy.
    Cilurzo F; Critello CD; Paolino D; Fiorillo AS; Fresta M; De Franciscis S; Celia C
    Colloids Surf B Biointerfaces; 2019 Mar; 175():469-476. PubMed ID: 30572155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary Experience With More Stable Polidocanol Foam in Sclerotherapy of Head and Neck Venous Malformations.
    Chen AW; Liu SH; Huang YY; Wang T
    Dermatol Surg; 2018 Nov; 44(11):1421-1426. PubMed ID: 29933299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.